[Federal Register Volume 85, Number 62 (Tuesday, March 31, 2020)]
[Notices]
[Page 17896]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-06691]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI SPORE (P50) I Review.
Date: May 18-19, 2020.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W116; Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Klaus B. Piontek, Ph.D., Scientific Review
Officer, Research Programs Review Branch, Division of Extramural
Activities, 9609 Medical Center Drive, Room 7W116, National Cancer
Institute, Rockville, MD 20892-9750, 240-276-5413,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI SPORE (P50) II Review.
Date: May 19-20, 2020.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, 7W244 Rockville, MD 20850 (Telephone Conference Call).
Contact Person: John Paul Cairns, Scientific Review Officer,
Research Programs Review Branch, Division of Extramural Activities,
9609 Medical Center Drive, Room 7W244, National Cancer Institute,
NIH, Bethesda, MD 20892, 240-276-5415, [email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI SPORE (P50) III Review.
Date: May 20-21, 2020.
Time: 8:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W122, Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Anita T. Tandle, Ph.D., Scientific Review
Officer, Research Programs Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W248, Bethesda, MD 20892, 240-276-5085,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; Quantitative Imaging Tools and Methods.
Date: May 21, 2020.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W640, Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Saejeong J. Kim, Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W640, Rockville, MD 20850, 240-276-7684, [email protected].
Name of Committee: National Cancer Institute Initial Review
Group; Subcommittee I--Transition to Independence.
Date: June 10-11, 2020.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W602, Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Delia Tang, M.D., Scientific Review Officer,
Research Programs Review Branch, Division of Extramural Activities,
National Cancer Institute. NIH, 9609 Medical Center Drive, Room
7W602, Bethesda, MD 20892, 240-276-6456, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: March 25, 2020.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-06691 Filed 3-30-20; 8:45 am]
BILLING CODE 4140-01-P